SCHEMBL20201474

SCHEMBL20201474

Cc1cccc(N2CN(C)c3cnccc32)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 5/20 0.38
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADRB1 P08588 1/20 0.36
FNTA P49354 2/20 0.35
FNTB P49356 2/20 0.35
KMT2A Q03164 1/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201469 0.94 CYP3A4 (0.41) CYP3A4CYP2C19LMNATSHRSMN1; SMN2
SCHEMBL17754707 0.88 FLT3 (0.39) SMN1; SMN2ALDH1A1TDP1ADRB1KMT2A
SCHEMBL20201468 0.82 CYP3A4 (0.44) CYP3A4CYP2C19LMNATSHRSMN1; SMN2
SCHEMBL17754710 0.82 FLT3 (0.39) SMN1; SMN2ALDH1A1TDP1ADRB1MAPT
SCHEMBL17173554 0.80 CYP17A1 (0.38) SMN1; SMN2ALDH1A1TDP1MAPTKDM4E
SCHEMBL20201475 0.77 MAPT (0.41) CYP3A4CYP2C19LMNATSHRSMN1; SMN2
SCHEMBL20201472 0.77 MAPT (0.41) CYP3A4CYP2C19LMNATSHRSMN1; SMN2
SCHEMBL26350115 0.75 CYP17A1 (0.39) ALDH1A1HTTMAPTGAANPSR1
SCHEMBL24187248 0.75 MAPT (0.40) SMN1; SMN2ALDH1A1TDP1MAPTKDM4E
SCHEMBL20201466 0.75 GAA (0.49) CYP3A4CYP2C19LMNATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES TEC, EML4, TPR CYP3A4 2528/4885CYP2C19 3024/4885LMNA 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.